Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2012, Article ID 937087, 4 pages
http://dx.doi.org/10.1100/2012/937087
Clinical Study

Expression and Clinical Significance of Antiapoptotic Gene (Survivin) in NB4 and Acute Promyelocytic Leukemia Cells

1Department of Hematology, Nanjing First Hospital Affiliated to Nanjing Medical University, NanJing 210006, China
2Department of Hematology, First Affiliated Hospital, Zhejiang University College of Medicine, Hangzhou 310009, China

Received 25 October 2011; Accepted 30 November 2011

Academic Editor: Xavier Thomas

Copyright © 2012 Jun Xue et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. Mao-Fang, M. Xiao-Li, and C. Zhen, “Expression and clinical significance of antiapoptosis gene, surviving, in acute leukemia,” Zhong Hua Journal of Hematology, vol. 23, pp. 251–253, 2002. View at Google Scholar
  2. C. Shai-Juan, C. Jing-Ren, and L. Xou-Shong, “The detection of PML/RARα fusion gene used with reverse transcription reaction in acute promyelocytic leukemia,” Zhong Hua Journal of Hematology, vol. 14, pp. 3–5, 1993. View at Google Scholar
  3. B. Z. Carter, M. Milella, D. C. Altieri, and M. Andreeff, “Cytokine-regulated expression of survivin in myeloid leukemia,” Blood, vol. 97, no. 9, pp. 2784–2790, 2001. View at Publisher · View at Google Scholar · View at Scopus
  4. C. Adida, C. Recher, E. Raffoux et al., “Expression and prognostic significance of surviving in de novo acute myeloid leukemia,” British Journal of Haematology, vol. 111, pp. 196–203, 2000. View at Google Scholar
  5. C. Adida, C. Haioun, P. Gaulard et al., “Prognostic significance of survivin expression in diffuse large B-cell lymphomas,” Blood, vol. 96, no. 5, pp. 1921–1925, 2000. View at Google Scholar · View at Scopus
  6. C. Üstün, M. Beksac, K. Dalva et al., “In vivo use of all-trans retinoic acid prior to induction chemotherapy improves complete remission rate and increases rhodamine 123 uptake in patients with de novo acute myeloid leukemia,” Medical Oncology, vol. 19, no. 1, pp. 59–67, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus